Baker Grants Office
Home Funding Contacts
Skip Navigation Links.
Home > Funding > Heart Foundation > Stroke Prevention Grants

Stroke Prevention Grants

Applications for Stroke Prevention Grants commencing in 2018 are closed.

Key dates

5 May 2017: Draft PDF version of application emailed to Research Office for compliance review and feedback.
10 May 2017: Final version of application submitted to Research Office for endorsement and final submission. *do not submit the application until you have received feedback and have been advised to do so by the Research Office*
12 May 2017: Heart Foundation closing date

Key changes to 2017 application process

  • Applications are now submitted via an online application process.
  • Applicants are required to collect Head of Department endorsement prior to submission.

Scheme description

This new one-off initiative from the Heart Foundation is open to experienced teams addressing the prevention of stroke, which may include areas such as atrial fibrillation, hypertension, vascular aspects of dementia, atherosclerosis and/or vascular biology of stroke. The Heart Foundation expects to contribute up to $3-5 million in total for the scheme and it is anticipated that 1-2 programs of up to five years duartion will be funded. The research team, who is expected to have a significant track record of national or international collaborations, should have the capacity to leverage additional funding.

The scheme involves a letter on intent stage, followed by a full application and an interview stage for shortlisted applicants. The Heart Foundation will be using a new online application system. Offline forms are available for information until the new online system opens.

Eligibility

  • The CIA must be an Australian or New Zealand citizen, Australian permanent resident or must have applied to become an Australian permanent resident.
  • All investigators can only be named as an investigator on one grant application.
  • The Heart Foundation-funded component of the research must be undertaken in Australia.

Application documentation

Research Office contacts

Rebecca Erlich 8532 1772
Cherry Yu 8532 1774

This page was last modified on 18/05/17

© Baker Heart and Diabetes Institute 2011-2016